Antidiabetic Properties of Coccinia Species in Experimental Models

Coccinia species, notably C. grandis, have long been employed in traditional medicine for the management of diabetes mellitus. Experimental investigations in vitro, in cell-based systems and in vivo rodent models have documented a spectrum of antidiabetic activities, ranging from enzymatic inhibition of carbohydrate hydrolysis to enhancement of insulin secretion and modulation of glucose transport. Crude leaf and fruit extracts, rich in flavonoids, phenolic acids and cucurbitacins, exhibit potent α-glucosidase and α-amylase inhibitory effects, attenuating postprandial hyperglycaemia. In cultured pancreatic β-cell lines and adipocytes, these extracts promote insulin release and ameliorate insulin resistance by upregulating GLUT4 expression and suppressing adipogenesis. In streptozotocin-induced diabetic rodents, administration of aqueous or ethanolic extracts has resulted in significant reductions in fasting blood glucose, improved lipid profiles and preservation of pancreatic islet morphology. Mechanistic studies attribute these outcomes to antioxidant properties, free-radical scavenging and modulation of key signalling pathways, including PPARγ and AMPK. More recently, isolation of specific glycosylated flavonoids such as rutin, nicotiflorin and quercetin derivatives has yielded compounds with submicromolar inhibitory potency against α-glucosidase, surpassing standard agents. A small human trial has further demonstrated a blood sugar-lowering effect following Coccinia leaf consumption in healthy volunteers, supporting translational potential. Collectively, these findings underscore the therapeutic promise of Coccinia species as sources of novel antidiabetic agents and justify continued phytopharmaceutical development.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Antidiabetic Properties of Coccinia Species in Experimental Models publication trend

The graph below shows the total number of articles in antidiabetic properties of coccinia species in experimental models across all publications each year (not limited to Nature Index journals).

Technical terms

α-Glucosidase: An intestinal enzyme that cleaves oligosaccharides to glucose, targeted to reduce postprandial hyperglycaemia.

UHPLC-HRMS/MS: Ultra-high-performance liquid chromatography paired with high-resolution tandem mass spectrometry for detailed metabolite profiling.

Molecular networking: A bioinformatic strategy to organise MS/MS spectral data into clusters reflecting structural similarity among compounds.

Flavonoid glycoside: A flavonoid molecule bound to a sugar moiety, often modulating solubility and bioactivity.

IC50: The concentration of an inhibitor required to reduce a biological or enzymatic activity by 50 per cent.

References

1. UHPLC‐HRMS/MS–Based Metabolic Profiling and Quantification of Phytochemicals in Different Parts of Coccinia grandis (L.) Voigt. Food Science & Nutrition (2025).
2. LC-QTOF-MS/MS Based Molecular Networking Approach for the Isolation of α-Glucosidase Inhibitors and Virucidal Agents from Coccinia grandis (L.) Voigt. Foods (2021).
3. Blood Sugar Lowering Effect of Coccinia grandis (L.) J. Voigt: Path for a New Drug for Diabetes Mellitus. Journal of Diabetes Research (2011).